Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta-new life for an old timer? Authors' reply

Aliment Pharmacol Ther. 2022 Sep;56(5):914-915. doi: 10.1111/apt.17138.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • Hepatitis D, Chronic* / drug therapy
  • Humans
  • Interferons*
  • Lipopeptides
  • Polyethylene Glycols

Substances

  • Antiviral Agents
  • Lipopeptides
  • bulevirtide
  • Polyethylene Glycols
  • Interferons